Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: Typical and atypical manifestations

Radiographics

Volumn 26, Issue SPEC. ISS., 2006, Pages

  Ukisu, Ryutarou ^a   Kushihashi, Tamio ^a   Tanaka, Eriko ^a   Baba, Maiko ^a   Usui, Nobutaka ^a   Fujisawa, Hidefumi ^a   Takenaka, Hiroki ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CLINICAL PRACTICE; CREUTZFELDT JAKOB DISEASE; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; PATHOLOGY; PRACTICE GUIDELINE; REVIEW;

BRAIN; CREUTZFELDT-JAKOB SYNDROME; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 34250701619     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.26si065503     Document Type: Review

References (47)

1. Prusiner SB. Shattuck lecture: neurodegenerative diseases and prions. N Engl J Med 2001;344(20):1516-1526.
2. Finkenstaedt M, Szudra A, Zerr I, et al. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996;199(3):793-798.
3. Barboriak DP, Provenzale JM, Boyko OB. MR diagnosis of Creutzfeldt-Jakob disease: significance of high signal intensity of the basal ganglia. AJR Am J Roentgenol 1994;162(1):137-140.
4. Demaerel P, Baert AL, Vanopdenbosch L, Robberecht W, Dom R. Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease. Lancet 1997;349(9055):847-848.
5. Bahn MM, Kido DK, Lin W, Pearlman AL. Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease. Arch Neurol 1997;54(11):1411-1415.
6. Schwaninger M, Winter R, Hacke W, et al. Magnetic resonance imaging in Creutzfeldt-Jakob disease: evidence of focal involvement of the cortex. J Neurol Neurosurg Psychiatry 1997;63(3):408-409.
7. Lee KE, Loh NK, Tan AK, Lee WL, Tjia HT. Creutzfeldt-Jakob disease presenting with visual blurring, diplopia and visual loss: Heidenhain's variant. Ann Acad Med Singapore 1998;27(6):854-856.
8. Yee AS, Simon JH, Anderson CA, Sze CI, Filley CM. Diffusion-weighted MRI of right-hemisphere dysfunction in Creutzfeldt-Jakob disease. Neurology 1999;52(7):1514-1515.
9. Samman I, Schulz-Schaeffer WJ, Wohrle JC, Sommer A, Kretzschmar HA, Hennerici M. Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2. J Neurol Neurosurg Psychiatry 1999;67(5):678-681.
10. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005;26(6):1551-1562.
11. Matoba M, Tonami H, Miyaji H, Yokota H, Yamamoto I. Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI. J Comput Assist Tomogr 2001;25(2):274-277.
12. Mao-Draayer Y, Braff SP, Nagle KJ, Pendlebury W, Penar PL, Shapiro RE. Emerging patterns of diffusion-weighted MR imaging in Creutzfeldt-Jakob disease: case report and review of the literature. AJNR Am J Neuroradiol 2002;23(4):550-556.
13. Murata T, Shiga Y, Higano S, Takahashi S, Mugikura S. Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging. AJNR Am J Neuroradiol 2002;23(7):1164-1172.
14. Ukisu R, Kushihashi T, Kitanosono T, et al. Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. AJR Am J Roentgenol 2005;184(2):560-566.
15. Demaerel P, Sciot R, Robberecht W, et al. Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt-Jakob disease. J Neurol 2003;250(2):222-225.
16. Hsiao K, Baker HF, Crow TJ, et al. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 1989;338(6213):342-345.
17. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease [letter]. N Engl J Med 1974;290(12):692-693.
18. Caboclo LO, Huang N, Lepski GA, et al. Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy: case report. Arq Neuropsiquiatr 2002;60(2-B):458-461.
19. Centers for Disease Control and Prevention (CDC). Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, 1979-2003. MMWR Morb Mortal Wkly Rep 2003;52(48):1179-1181.
20. Johnson RT, Gibbs CJ Jr. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339(27):1994-2004.
21. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347(9006):921-925.
22. Zeidler M, Stewart GE, Barraclough CR, et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 1997;350(9082):903-907.
23. Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull 2003;66(1):255-265.
24. Caramelli M, Ru G, Acutis P, Forloni G. Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances. CNS Drugs 2006;20(1):15-28.
25. DeArmond SJ, Kretzschmar HA, Prusiner SB. Prion diseases. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology. 7th ed. London, England: Arnold, 2002; 273-323.
26. Green AJ. Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2002;28(6):427-440.
27. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Committee on Health Care Issues, American Neurological Association. Ann Neurol 1986;19(1):75-77.
28. Smith AJ, Sweeney MP, Bagg J. Prion diseases and dental treatment: principles and practice of patients with/suspected or at-risk of CJD: case reports. Br Dent J 2003;195(6):319-321.
29. Pauli G. Tissue safety in view of CJD and variant CJD. Cell Tissue Bank 2005;6(3):191-200.
30. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363(9407):417-421.
31. Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977;1(8009):478-479.
32. Benito-Leon J. Combined quinacrine and chlorpromazine therapy in fatal familial insomnia. Clin Neuropharmacol 2004;27(4):201-203.
33. Pandya HG, Coley SC, Wilkinson ID, Griffiths PD. Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease. Clin Radiol 2003;58(2):148-153.
34. Sunada I, Ishida T, Sakamoto S, Tsuyuguchi N. A discrepancy between Tc-99m HMPAO SPECT and Tc-99m ECD SPECT in Creutzfeldt-Jacob disease. J Clin Neurosci 2004;11(6):648-650.
35. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217(2):331-345.
36. Iizuka T, Sakai F, Kan S, Suzuki N. Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 2003;61(4):1238-1244.
37. Wang XY, Noguchi K, Takashima S, Hayashi N, Ogawa S, Seto H. Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema. Neuroradiology 2003;45(9):640-643.
38. Kolb SJ, Costello F, Lee AG, et al. Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci 2003;216(1):11-15.
39. Hurst RW, Bagley LJ, Galetta S, et al. Dementia resulting from dural arteriovenous fistulas: the pathologic findings of venous hypertensive encephalopathy. AJNR Am J Neuroradiol 1998;19(7):1267-1273.
40. Tominaga T, Shamoto H, Shimizu H, Watanabe M, Yoshimoto T. Selective loss of Purkinje cells in transverse and sigmoid dural arteriovenous fistulas: report of two cases. J Neurosurg 2003;98(3):617-620.
41. Hammoud D, Beauchamp N, Wityk R, Yousem D. Ischemic complication of a cerebral developmental venous anomaly: case report and review of the literature. J Comput Assist Tomogr 2002;26(4):633-636.
42. Lee SK, Willinsky RA, Montanera W, terBrugge KG. MR imaging of dural arteriovenous fistulas draining into cerebellar cortical veins. AJNR Am J Neuroradiol 2003;24(8):1602-1606.
43. Sage JI, Weinstein MP, Miller DC. Chronic encephalitis possibly due to herpes simplex virus: two cases. Neurology 1985;35(10):1470-1472.
44. Hori T, Suzuki T, Terashima Y, Kawai N, Shiraishi H, Koizumi J. Chronic herpes simplex encephalitis with somnambulism: CT, MR and SPECT findings. Jpn J Psychiatry Neurol 1990;44(4):735-739.
45. Heiner L, Demaerel P. Diffusion-weighted MR imaging findings in a patient with herpes simplex encephalitis. Eur J Radiol 2003;45(3):195-198.
46. Kuker W, Nagele T, Schmidt F, Heckl S, Herrlinger U. Diffusion-weighted MRI in herpes simplex encephalitis: a report of three cases. Neuroradiology 2004;46(2):122-125.
47. Burke JW, Mathews VP, Elster AD, Ulmer JL, McLean FM, Davis SB. Contrast-enhanced magnetization transfer saturation imaging improves MR detection of herpes simplex encephalitis. AJNR Am J Neuroradiol 1996;17(4):773-776.